Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
The trial has three separate groups. People may be considered for one of the following:
Fragile X Syndrome (FXS) Group:
- Children between 5 and 10 years old (inclusive)
- Children who have had a genetic test confirming a full FMR1 gene mutation (the genetic change that causes Fragile X Syndrome)
Autism Spectrum Disorder (ASD) Group:
- Children between 5 and 10 years old (inclusive)
- Children with no known genetic mutation
- Children who have a formal documented diagnosis of ASD
- Children who score 15 or below on a specific screening questionnaire called the SCQ (confirm with trial site)
- Children who the trial doctor considers to be in good general health
Typical Development Control (TDC) Group:
- Children between 5 and 10 years old (inclusive)
- Children with no known genetic mutation
- Children who have a formal documented diagnosis of ASD
- Children who score 8 or below on the SCQ screening questionnaire
- Children who the trial doctor considers to be in good general health
- Children who have reached normal developmental milestones
- Children with no family history of inherited neurological or psychiatric conditions
- Children who score above 85 on a cognitive assessment called the Stanford-Binet IQ test
Who may not be able to join:
- Children who have hearing or vision problems that cannot be fully corrected with aids or glasses
- Children who have had a history of alcohol or drug misuse or dependence within the past 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ernest V Pedapati, MD, Children's Hospital Medical Center, Cincinnati
Phone: 513-636-0875
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Alpha auditory entrainment versus sham effect on Word Learning Index during the Statistical Learning Passive Task.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.